Concert Genetics
Gillian is Concert’s Chief Scientific Officer and the immediate past President of the National Society of Genetic Counselors. She also serves as an adjunct Associate Professor with the Vanderbilt University Medical Center and leads the Research arm of the Vanderbilt Genetic Counseling Training Program. Applying her background in molecular and clinical genetics, genetic counseling and behavioral science, she is committed to overcoming the barriers to effective translation of genome science at the patient, provider and system levels. As a researcher in academic and government settings, Gillian has worked with numerous transdisciplinary teams on the front lines of genomics, developing and evaluating methods for delivering genomic information to patients and their providers. Having served as the associate director of a genetic counseling training program, Gillian also brings significant experience in genetics education and outreach.
Gillian completed her doctoral degree in Molecular, Cellular and Developmental Biology at Yale University and her masters degree in Genetic Counseling at the Johns Hopkins School of Public Health / National Human Genome Research Institute Genetic Counseling Training Program. She grew up in Kalamazoo, Michigan and attended Kalamazoo College.
This person is not in any offices
Concert Genetics
Genetic testing is the lynchpin of precision medicine, but the rapid pace of change in the market makes it enormously complex. Today, there are more than 75,000 unique genetic testing products on the market, and an average of 10 new products are added each day. This growth confounds the processes through which tests are ordered, resulted, billed and reimbursed. Founded in 2010 with a vision to simplify this complexity, Concert Genetics (formerly NextGxDx, Inc.) launched as a healthcare technology company dedicated to streamlining the genetic test selection, ordering, payment and management for clinicians, hospitals, laboratories and health plans. With a leading team of clinicians, researchers, data scientists and software engineers, Concert Genetics launched its proprietary solutions to enable end-to-end genetic testing management, from searching and comparing testing products, to tracking orders and results, to payment integrity and forecasting trends in pricing and utilization. Today, stakeholders across the healthcare system turn to Concert Genetics to better understand and navigate the rapid transformation to precision medicine that is underway.